S&P 500Bucket avgCompareDividend-adjusted total return · S&P 500 uses VOO · Dec 31, 2025 – Nov 19, 2026
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.2% | −5.4% | +0.6% | −10.4% | +17.0% | +25.8% | — | — | — | +71.4% |
| Peer average | −2.0% | −6.1% | −9.2% | −10.0% | +1.3% | +4.5% | +60.3% | +6.8% | +311.1% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$103 of every $1,000 in LFSC is Replimune
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | REPLReplimune Group | Healthcare | 10.35% | $1,034.65 | 616K | $12.7M |
| 2 | LIVNLivaNova | Healthcare | 7.96% | $796.15 | 105K | $9.8M |
| 3 | COGTCogent Biosciences | Healthcare | 5.84% | $584.04 | 264K | $7.2M |
| 4 | TVTXTravere Therapeutics | Healthcare | 5.61% | $561.11 | 139K | $6.9M |
| 5 | UTHRUnited Therapeutics | Healthcare | 4.88% | $488.05 | 10K | $6.0M |
| 6 | MIRMMirum Pharmaceuticals | Healthcare | 4.52% | $451.75 | 61K | $5.5M |
| 7 | GHGuardant Health | Healthcare | 4.40% | $440.21 | 37K | $5.4M |
| 8 | BLLNBilliontoone | Healthcare | 4.24% | $423.78 | 54K | $5.2M |
| 9 | SYRESpyre Therapeutics | Healthcare | 4.03% | $402.71 | 51K | $4.9M |
| 10 | CYTKCytokinetics | Healthcare | 3.92% | $391.82 | 92K | $4.8M |
| 11 | TMDXTransMedics Group | Healthcare | 3.82% | $381.74 | 50K | $4.7M |
| 12 | MANEVeraDermics | Healthcare | 3.76% | $375.73 | 37K | $4.6M |
| 13 | SVRASavara | Healthcare | 3.45% | $344.63 | 943K | $4.2M |
| 14 | ICUIICU Medical | Healthcare | 2.98% | $298.23 | 20K | $3.7M |
| 15 | AXSMAxsome Therapeutics | Healthcare | 2.55% | $254.95 | 23K | $3.1M |
LFSC does not pay a distribution.
of the $46.9B in 27 Disruptive tech ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | REPL | Replimune Group | 10.35% |
| 2 | LIVN | LivaNova | 7.96% |
| 3 | COGT | Cogent Biosciences | 5.84% |
| 4 | TVTX | Travere Therapeutics | 5.61% |
| 5 | UTHR | United Therapeutics | 4.88% |
| 6 | MIRM | Mirum Pharmaceuticals | 4.52% |
| 7 | GH | Guardant Health | 4.40% |
| 8 | BLLN | Billiontoone | 4.24% |
| 9 | SYRE | Spyre Therapeutics | 4.03% |
| 10 | CYTK | Cytokinetics | 3.92% |
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]